NEMO coiled coil mimics and methods of using same
AssigneeNew York University
InventorsParamjit S. Arora, Michael G. Wuo
Life of this patent
Estimating the term…
Abstract
This invention relates to macrostructures (and pharmaceutical formulations containing them) that include a parallel coiled-coil structure, wherein the parallel coiled-coil comprises a first coil of Formula I and a second coil of Formula II: T1-f0-g0-a1-b1-c1-d1-e1-f1-g1-a2-b2-c2-d2-e2-f2-g2-a3-b3-c3-d3-e3-T2 (I) T3-g′0-a′1-b′1-c′1-d′1-e′1-f′1-g′1-a′2-b′2-c′2-d′2-e′2-f′2-g′2-a′3-b′3-c′3-d′3-e′3-f′3-T4 (II), as described in the present application. Methods of using these macrostructures are also disclosed.
Claims9
A macrostructure comprising a parallel coiled-coil, wherein the parallel coiled-coil comprises:
- a first coil of Formula I and a second coil of Formula II:
- T1-f0-g0-a1-b1-c1-d1-e1-f1-g1-a2-b2-c2-d2-e2-f2-g2-a3-b3-c3-d3-e3-T2 (Formula I) (SEQ ID NO:
- 1)
- T3-g′0-a′1-b′1-c′1-d′1-e′1-f′1-g′1-a′2-b′2-c′2-d′2-e′2-f′2-g′2-a′3-b′3-c′3-d′3-e′3-f′3-T4 (Formula II) (SEQ ID NO:
- 2),
- wherein:
- each a1-3, b1-3, c1-3, d1-3, e1-3, f0-2, g0-2, a′1-3, b′1-3, c′1-3, d′1-3, e′1-3, f′1-3, and g′0-2 is independently absent or a residue selected from the group consisting of modified or unmodified amino acid residues and analogues thereof,
- one or more of the following residue pairs are covalently bound by a linker:
- g0-e′1, g1-e′2, g2-e′3, d1-d′1, d2-d′2, d3-d′3, a1-a′1, a2a′2, a3-a3, e1-g′0, e2-g′1, and e3-g′2;
- each T1 and T3 is independently a point of attachment from a terminal nitrogen to one or more moieties, wherein each moiety is independently H, -PG1, —C(O)R, —C(O)NR2, —C(O)NH2, —R, —C(O)OR, an amino acid or analogue thereof, a peptide, a targeting moiety, or a tag, where PG1 is an amine protecting group and each R is independently hydrogen, an alkyl, an alkenyl, an alkynyl, a cycloalkyl, an aryl, a heteroaryl, a heterocyclyl, an arylalkyl, a peptide, a targeting moiety, or a tag;
- and
- each T2 and T4 is independently a point of attachment from a terminal carbonyl to H, —OPG2, —NPG2, —OR, —OH, —NR2, —NH2, —N(R)C(O)C1-6 alkyl, —N(H)C(O)C1-6 alkyl, an amino acid or analogue thereof, a peptide, a targeting moiety, or a tag, where PG2 is a carboxylic acid protecting group and each R is independently hydrogen, an alkyl, an alkenyl, an alkynyl, a cycloalkyl, an aryl, a heteroaryl, a heterocyclyl, an arylalkyl, a peptide, a targeting moiety, or a tag;
- and wherein:
- the first coil comprises fourteen contiguous residues which correlate to positions f0-e2 of Formula I, wherein said fourteen contiguous residues of the first coil have the amino acid sequence of SEQ ID NO:
- 4;
- and the second coil comprises fourteen contiguous residues which correlate to positions g′0-f′2 of Formula II, wherein said fourteen contiguous residues of the second coil have the amino acid sequence of SEQ ID NO:
- 6.
Dependencies are inferred from the claim text.